Thorsten Herrmann to lead CGM’s business in Germany
CompuGroup Medical appoints Thorsten Herrmann as Managing Director for Germany, effective April 1, 2026, covering all customer segments.
Image: CompuGroup Medical
Gilead Extends Tender Offer for Arcellx
Gilead has extended its tender offer to acquire Arcellx until April 24, 2026. The offer remains $115 per share in cash plus a CVR.
One A Day teams up with Ludacris for social-first wellness campaign
Bayer’s One A Day partners with Ludacris on a social-first campaign using humor to challenge extreme wellness trends and highlight simple routines.
Veeva launches AI agents for Vault CRM and PromoMats
Veeva makes AI agents available for Vault CRM and PromoMats. The capabilities target field-force workflows and content review in life sciences.
IQVIA: German pharma market up in value in 2025, volumes slightly down
IQVIA reports 5.7% sales growth in Germany’s pharma market in 2025, while volumes slipped by 0.7%. In pharmacies, Rx grew faster than OTC.
US class action targets Novartis over data sharing on branded drug websites
A US class action alleges Novartis shared sensitive data from branded drug websites without consent, raising questions about tracking and third-party analytics.
AbbVie named MLB’s official pharmaceutical partner from 2026
AbbVie has signed a multi-year MLB partnership starting in 2026, expanding “Striking Out Cancer” league-wide with donations to Stand Up To Cancer.
Gilead to acquire Ouro Medicines for clinical BCMAxCD3 program
Gilead Sciences plans to buy Ouro Medicines for up to $2.175bn, adding OM336, a clinical BCMAxCD3 T cell engager for autoimmune diseases.
Jenoptik appoints Dr. Dominic Dorfner as future CEO
Jenoptik’s Supervisory Board has appointed Dr. Dominic Dorfner as future CEO. He is expected to take office no later than 1 October 2026.
Stefan Betzold to leave Bauer Media Group
Stefan Betzold is leaving Bauer Media Group. The Managing Director of Bauer Xcel Media will support the transition of responsibilities.